These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 29757021

  • 1. Advagraf® with or without an induction therapy for de novo kidney-transplant recipients.
    Noble J, Jouve T, Rostaing L, Malvezzi P.
    Expert Rev Clin Immunol; 2018 Jun; 14(6):461-467. PubMed ID: 29757021
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
    Haasova M, Snowsill T, Jones-Hughes T, Crathorne L, Cooper C, Varley-Campbell J, Mujica-Mota R, Coelho H, Huxley N, Lowe J, Dudley J, Marks S, Hyde C, Bond M, Anderson R.
    Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels.
    Crespo M, Mir M, Marin M, Hurtado S, Estadella C, Gurí X, Rap O, Moral R, Puig JM, Lloveras J.
    Transplant Proc; 2009 Aug; 41(6):2115-7. PubMed ID: 19715848
    [Abstract] [Full Text] [Related]

  • 9. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
    Staatz CE, Tett SE.
    Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Once- versus twice-daily tacrolimus: are the formulations truly equivalent?
    Barraclough KA, Isbel NM, Johnson DW, Campbell SB, Staatz CE.
    Drugs; 2011 Aug 20; 71(12):1561-77. PubMed ID: 21861541
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment.
    Ma MK, Kwan LP, Mok MM, Yap DY, Tang CS, Chan TM.
    Ren Fail; 2013 Aug 20; 35(7):942-5. PubMed ID: 23815459
    [Abstract] [Full Text] [Related]

  • 16. One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients.
    Silva HT, Yang HC, Abouljoud M, Kuo PC, Wisemandle K, Bhattacharya P, Dhadda S, Holman J, Fitzsimmons W, First MR.
    Am J Transplant; 2007 Mar 20; 7(3):595-608. PubMed ID: 17217442
    [Abstract] [Full Text] [Related]

  • 17. Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence.
    Muduma G, Odeyemi I, Smith-Palmer J, Pollock RF.
    Patient Prefer Adherence; 2014 Mar 20; 8():391-9. PubMed ID: 24729687
    [Abstract] [Full Text] [Related]

  • 18. Prograf produces more benefits for CYP3A5 low expression patients in early stage after kidney transplantation.
    Fan B, Qiu K, Jiang Y, Hu X, Yin H, Wang W, Ren L, Liu H, Wang W, Zhang X.
    Biomed Pharmacother; 2017 Apr 20; 88():738-744. PubMed ID: 28157649
    [Abstract] [Full Text] [Related]

  • 19. Conversion from Prograf to Advagraf among kidney transplant recipients results in sustained decrease in tacrolimus exposure.
    Hougardy JM, Broeders N, Kianda M, Massart A, Madhoun P, Le Moine A, Hoang AD, Mikhalski D, Wissing KM, Abramowicz D.
    Transplantation; 2011 Mar 15; 91(5):566-9. PubMed ID: 21192316
    [Abstract] [Full Text] [Related]

  • 20. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 15; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.